Intercept Pharmaceuticals, Inc.

NATIXIS

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

120,000

Value ($000)

2,225

Weight

0.0%

2020 Q4 - 2023 Q3 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	2,225	0.0%	120,000	9/30/2023
2023 Q2	8/11/2023	106	0.0%	9,571	6/30/2023
2023 Q1	5/12/2023	51	0.0%	3,763	3/31/2023
2022 Q4	2/24/2023	49	0.0%	3,998	12/31/2022
2020 Q4	2/12/2021	250	0.0%	10,110	12/31/2020